Drug Combo Shows Benefits in Fit Patients With Acute Myeloid Leukemia

(MedPage Today) — ORLANDO — Azacitidine and venetoclax (Venclexta) significantly improved event-free survival (EFS) in newly diagnosed fit adults with acute myeloid leukemia (AML) compared with conventional induction chemotherapy, a phase II…

Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118890

Author :

Publish date : 2025-12-08 18:49:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Drug Combo Shows Benefits in Fit Patients With Acute Myeloid Leukemia

Many Patients Still Face GP Referral ‘Black Hole’

Dual Targeting of GPRC5D and BCMA Gets High Response Rate in Extramedullary Myeloma

Related Posts

No, Those Aren’t Really ‘Holes’ in Kim Kardashian’s Brain

AI Isn’t the Solution for Every Problem

TikTok Hotbed for Allergy, Asthma Misinformation

New Device Uses Steam to Kill Prostate Cancer

Trial Results Could Shuffle Order of BTK Inhibitors for CLL/SLL

Dual Targeting of GPRC5D and BCMA Gets High Response Rate in Extramedullary Myeloma

No, Those Aren’t Really ‘Holes’ in Kim Kardashian’s Brain

AI Isn’t the Solution for Every Problem

TikTok Hotbed for Allergy, Asthma Misinformation

New Device Uses Steam to Kill Prostate Cancer

Trial Results Could Shuffle Order of BTK Inhibitors for CLL/SLL

Dual Targeting of GPRC5D and BCMA Gets High Response Rate in Extramedullary Myeloma

Drug Combo Shows Benefits in Fit Patients With Acute Myeloid Leukemia

Many Patients Still Face GP Referral ‘Black Hole’

Categories

Archives